EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC – Get Free Report)’s stock price shot up 90.5% during trading on Wednesday . The stock traded as high as $0.2479 and last traded at $0.2479. 110 shares traded hands during trading, a decline of 89% from the average session volume of 1,013 shares. The stock had previously closed at $0.1301.
EOM Pharmaceutical Stock Down 15.8%
The company’s fifty day moving average is $0.19 and its two-hundred day moving average is $0.16.
About EOM Pharmaceutical
EOM Pharmaceutical, trading under the ticker OTCMKTS:IMUC, is a clinical-stage biotechnology company focused on the development of cell-based immunotherapies for the treatment of solid tumors. The company leverages dendritic cell technology to create personalized therapeutic vaccines designed to activate a patient’s immune system against tumor-specific antigens. By harnessing key insights into antigen presentation and T-cell activation, EOM Pharmaceutical aims to improve survival outcomes for patients with cancers that currently have limited treatment options.
The company’s lead programs are directed at glioblastoma multiforme and other aggressive tumor types, where standard therapies often fall short.
Featured Articles
- Five stocks we like better than EOM Pharmaceutical
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for EOM Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
